The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Labrosse Nicole since 2022.
This trader's CIK number is 1910662.
At the time of last reporting, Labrosse Nicole was the SVP, CHIEF FINANCIAL OFFICER of Halozyme Therapeutics, Inc.. (stock ticker symbol HALO).
Also see all insider trading activities at Halozyme Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | HALO | 0 | $0 | 0 | $0 | 64,858 | $0 |
| 2024 | HALO | 0 | $0 | 35,000 | $1,828,205 | 46,676 | $787,500 |
| 2023 | HALO | 0 | $0 | 2,525 | $124,381 | 10,240 | $0 |
| 2022 | HALO | 0 | $0 | 5,000 | $268,775 | 6,403 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-23 | HALO | Option Ex | 6,688 | .00 | 0 |
| 2025-02-16 | HALO | Option Ex | 27,831 | .00 | 0 |
| 2025-02-15 | HALO | Option Ex | 1,254 | .00 | 0 |
| 2025-02-16 | HALO | Option Ex | 27,831 | .00 | 0 |
| 2025-02-15 | HALO | Option Ex | 1,254 | .00 | 0 |
| 2024-07-22 | HALO | Sale | 5,000 | 54.05 | 270,265 |
| 2024-07-22 | HALO | Option Ex | 5,000 | 22.50 | 112,500 |
| 2024-06-26 | HALO | Option Ex | 10,000 | 22.50 | 225,000 |
| 2024-06-27 | HALO | Option Ex | 10,000 | 22.50 | 225,000 |
| 2024-06-26 | HALO | Sale | 10,000 | 51.82 | 518,200 |
| 2024-06-28 | HALO | Option Ex | 10,000 | 22.50 | 225,000 |
| 2024-06-27 | HALO | Sale | 10,000 | 51.93 | 519,340 |
| 2024-06-28 | HALO | Sale | 10,000 | 52.04 | 520,400 |
| 2024-02-16 | HALO | Option Ex | 10,422 | .00 | 0 |
| 2024-02-15 | HALO | Option Ex | 1,254 | .00 | 0 |
| 2023-02-16 | HALO | Option Ex | 5,094 | .00 | 0 |
| 2023-02-16 | HALO | Sale | 2,525 | 49.26 | 124,381 |
| 2023-02-15 | HALO | Option Ex | 1,254 | .00 | 0 |
| 2023-02-12 | HALO | Option Ex | 1,389 | .00 | 0 |
| 2023-02-10 | HALO | Option Ex | 2,503 | .00 | 0 |
| 2022-11-15 | HALO | Sale | 5,000 | 53.76 | 268,775 |
| 2022-02-15 | HALO | Option Ex | 1,255 | .00 | 0 |
| 2022-02-10 | HALO | Option Ex | 2,503 | .00 | 0 |
| 2022-02-12 | HALO | Option Ex | 1,389 | .00 | 0 |
| 2022-02-14 | HALO | Option Ex | 1,256 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Labrosse Nicole (SVP, CHIEF FINANCIAL OFFICER of Halozyme Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.